Twin Tree Management, LP has disclosed its latest holdings in a recent 13F filing, revealing a total value of approximately $4.87 billion. This filing, dated November 10, 2026, is significant as it provides insights into the firm’s investment strategies and positions across various sectors.

As an asset management firm based in Dallas, Texas, Twin Tree Management specializes in investment management. The firm operates under the Central Index Key (CIK) 0001535588 and has been active in filing various reports with the SEC, including the recent 13F-HR.

The filing indicates that as of September 30, 2026, Twin Tree Management managed a total of 1,320 positions, with a cumulative value of $4,872,788,716. The firm’s Chief Financial Officer and Chief Compliance Officer, Joe Chiang, signed the document, affirming its accuracy and compliance with SEC regulations.

Among the notable holdings listed in the filing are significant positions in major corporations such as 3M Company and Abbott Laboratories. The firm’s investment discretion is marked as sole for these positions, indicating a focused investment strategy.

This disclosure is relevant not only for investors tracking Twin Tree Management but also for the broader asset management industry. It provides a glimpse into the firm’s strategic decisions and could influence the investment approaches of competitors. The filing showcases the importance of transparency in investment management, as firms are required to report their holdings periodically.

Looking ahead, it remains to be seen how Twin Tree Management will adjust its investment strategies in response to market conditions and economic trends. The filing does not specify any forthcoming actions or changes in strategy, leaving stakeholders to interpret the implications of this substantial asset disclosure.